BARBARA JOANNA HERRING
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner JACKSON, MS NPI 1699401760
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner MS Incyte Corporation All categories
General Payments — all program years on this page
$1,323.28
- Category: General Payments
- Program years: PY2021–2024
- Record count: 66
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,032.27 across 54 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,032.27 | 54 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $170.34 | 11 |
| Merck Sharp & Dohme Corporation | $87.89 | 5 |
| Acerta Pharma LLC | $84.19 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $82.91 | 4 |
| Janssen Biotech, Inc. | $70.96 | 4 |
| Genentech USA, Inc. | $59.46 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $58.15 | 2 |
| Stemline Therapeutics Inc. | $45.08 | 2 |
| AVEO Pharmaceuticals, Inc. | $39.96 | 2 |
| Daiichi Sankyo Inc. | $39.85 | 2 |
| Novo Nordisk AS | $38.99 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33.99 | 2 |
| PUMA BIOTECHNOLOGY, INC. | $30.31 | 2 |
| Alexion Pharmaceuticals, Inc. | $26.00 | 1 |
| Rigel Pharmaceuticals, Inc. | $25.63 | 1 |
| PharmaEssentia USA Corporation | $25.16 | 1 |
| Legend Biotech USA Inc. | $22.56 | 1 |
| Lilly USA, LLC | $20.79 | 1 |
| Adaptive Biotechnologies Corporation | $20.29 | 1 |
| EMD Serono, Inc. | $18.13 | 1 |
| Coherus Biosciences Inc. | $17.80 | 1 |
| Acrotech Biopharma Inc. | $13.83 | 1 |
By program year
Records — PY2024 (54)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.